PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Stem Cell Program of Clinical Research Center, Henan Provincial People\'s Hospital and People\'s Hospital of Zhengzhou University, Zhengzhou 450003, People\'s Republic of China.\', \'Henan Key Laboratory of Stem Cell Differentiation and Modification, Zhengzhou 450003, People\'s Republic of China.\', \'Reproductive Medicine Institute, Henan Provincial People\'s Hospital and People\'s Hospital of Zhengzhou University, Zhengzhou 450003, People\'s Republic of China.\', \'People\'s Hospital of Henan University, Zhengzhou 450003, People\'s Republic of China.\', \'Department of Neurosurgery, Henan Provincial People\'s Hospital and People\'s Hospital of Zhengzhou University, Zhengzhou 450003, People\'s Republic of China.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.2147/DDDT.S269407
?:hasPublicationType
?:journal
  • Drug design, development and therapy
is ?:pmid of
?:pmid
?:pmid
  • 33061304
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.974
?:rankingScore_hIndex
  • 40
?:title
  • Challenges for Mesenchymal Stem Cell-Based Therapy for COVID-19.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all